Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/22919
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2021-12-01T07:58:29Z | - |
dc.date.available | 2021-12-01T07:58:29Z | - |
dc.date.issued | 2001-03 | - |
dc.identifier.citation | Usta, M. vd. (2001). "Anti-proteinuric effect of angiotension II receptor antagonist losartan in cases with glomerular lesions". Clinical Nephrology, 55(3), 260-262. | tr_TR |
dc.identifier.issn | 0301-0430 | - |
dc.identifier.uri | http://hdl.handle.net/11452/22919 | - |
dc.language.iso | en | tr_TR |
dc.publisher | Dustri | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | tr_TR |
dc.subject | Converting | tr_TR |
dc.subject | Enzyme | tr_TR |
dc.subject | Inhibitor | tr_TR |
dc.subject | Urology & nephrology | tr_TR |
dc.subject.mesh | Humans | tr_TR |
dc.subject.mesh | Antihypertensive agents | tr_TR |
dc.subject.mesh | Female | tr_TR |
dc.subject.mesh | Glomerulonephritis | tr_TR |
dc.subject.mesh | Kidney glomerulus | tr_TR |
dc.subject.mesh | Losartan | tr_TR |
dc.subject.mesh | Male | tr_TR |
dc.subject.mesh | Proteinuria | tr_TR |
dc.subject.mesh | Receptors, angiotensin | tr_TR |
dc.title | Anti-proteinuric effect of angiotension II receptor antagonist losartan in cases with glomerular lesions | tr_TR |
dc.type | Letter | tr_TR |
dc.identifier.wos | 000172184000014 | tr_TR |
dc.identifier.scopus | 2-s2.0-0035105081 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Nefroloji Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-0710-0923 | tr_TR |
dc.identifier.startpage | 260 | tr_TR |
dc.identifier.endpage | 262 | tr_TR |
dc.identifier.volume | 55 | tr_TR |
dc.identifier.issue | 3 | tr_TR |
dc.relation.journal | Clinical Nephrology | tr_TR |
dc.contributor.buuauthor | Usta, Mehmet | - |
dc.contributor.buuauthor | Dilek, Kamil | - |
dc.contributor.buuauthor | Yavuz, Mahmut | - |
dc.contributor.buuauthor | Ersoy, Alparslan | - |
dc.contributor.buuauthor | Güllülü, Mustafa | - |
dc.contributor.buuauthor | Yurtkuran, Mustafa Abbas | - |
dc.contributor.researcherid | AAH-5054-2021 | tr_TR |
dc.identifier.pubmed | 11316250 | tr_TR |
dc.subject.wos | Urology & nephrology | tr_TR |
dc.indexed.wos | SCIE | tr_TR |
dc.indexed.scopus | Scopus | tr_TR |
dc.indexed.pubmed | Pubmed | tr_TR |
dc.wos.quartile | Q2 | tr_TR |
dc.contributor.scopusid | 7005030712 | tr_TR |
dc.contributor.scopusid | 56005080200 | tr_TR |
dc.contributor.scopusid | 7006244754 | tr_TR |
dc.contributor.scopusid | 35612977100 | tr_TR |
dc.contributor.scopusid | 6602684544 | tr_TR |
dc.contributor.scopusid | 7003389525 | tr_TR |
dc.subject.scopus | Renin Angiotensin Aldosterone System; Angiotensin Receptor Antagonists; Diabetic Nephropathies | tr_TR |
dc.subject.emtree | Renin | tr_TR |
dc.subject.emtree | Angiotensin | tr_TR |
dc.subject.emtree | Angiotensin 2 receptor antagonist | tr_TR |
dc.subject.emtree | Dipeptidyl carboxypeptidase inhibitor | tr_TR |
dc.subject.emtree | Enalapril | tr_TR |
dc.subject.emtree | Losartan | tr_TR |
dc.subject.emtree | Drug effect | tr_TR |
dc.subject.emtree | Adult | tr_TR |
dc.subject.emtree | Alport syndrome | tr_TR |
dc.subject.emtree | Clinical article | tr_TR |
dc.subject.emtree | Controlled study | tr_TR |
dc.subject.emtree | Diabetic nephropathy | tr_TR |
dc.subject.emtree | Glomerulonephritis | tr_TR |
dc.subject.emtree | Drug selectivity | tr_TR |
dc.subject.emtree | Drug specificity | tr_TR |
dc.subject.emtree | Essential hypertension | tr_TR |
dc.subject.emtree | Female | tr_TR |
dc.subject.emtree | Focal glomerulosclerosis | tr_TR |
dc.subject.emtree | Glomerulopathy | tr_TR |
dc.subject.emtree | Glomerulosclerosis | tr_TR |
dc.subject.emtree | Membranous glomerulonephritis | tr_TR |
dc.subject.emtree | Glomerulus filtration | tr_TR |
dc.subject.emtree | Glomerulus filtration rate | tr_TR |
dc.subject.emtree | Immunoglobulin A nephropathy | tr_TR |
dc.subject.emtree | Human | tr_TR |
dc.subject.emtree | Histopathology | tr_TR |
dc.subject.emtree | Immunosuppressive treatment | tr_TR |
dc.subject.emtree | Kidney biopsy | tr_TR |
dc.subject.emtree | Kidney disease | tr_TR |
dc.subject.emtree | Kidney function | tr_TR |
dc.subject.emtree | Kidney plasma flow | tr_TR |
dc.subject.emtree | Letter | tr_TR |
dc.subject.emtree | Male | tr_TR |
dc.subject.emtree | Membranoproliferative glomerulonephritis | tr_TR |
dc.subject.emtree | Protection | tr_TR |
dc.subject.emtree | Proteinuria | tr_TR |
dc.subject.emtree | Renin angiotensin aldosterone system | tr_TR |
dc.subject.emtree | Risk factor | tr_TR |
Appears in Collections: | Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.